Myocardial fat accumulation is associated with cardiac dysfunction in patients with type 2 diabetes, especially in elderly or female patients: a retrospective observational study

[1]  P. Guzzi,et al.  Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance , 2023, Cardiovascular Diabetology.

[2]  Oana M Aburel,et al.  The Role and Implications of Epicardial Fat in Coronary Atherosclerotic Disease , 2022, Journal of clinical medicine.

[3]  B. Bakker,et al.  Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma , 2022, Frontiers in Cardiovascular Medicine.

[4]  C. Enrich,et al.  Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  S. Musani,et al.  Patients phenotypes and cardiovascular risk in type 2 diabetes: the Jackson Heart Study , 2022, Cardiovascular Diabetology.

[6]  Zahra Moghimi,et al.  Lipids and diastolic dysfunction: Recent evidence and findings. , 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[7]  Y. Chiao,et al.  Age and Sex Differences in Heart Failure With Preserved Ejection Fraction , 2022, Frontiers in Aging.

[8]  R. Marfella,et al.  Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes , 2022, Biomolecules.

[9]  F. Ng,et al.  Epicardial adipose tissue as a mediator of cardiac arrhythmias , 2021, American journal of physiology. Heart and circulatory physiology.

[10]  G. Paolisso,et al.  Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts. , 2021, Metabolism: clinical and experimental.

[11]  A. Vidal-Puig,et al.  Lipotoxicity: a driver of heart failure with preserved ejection fraction? , 2021, Clinical science.

[12]  I. Shimomura,et al.  Ectopic Fat Accumulation in Pancreas and Heart , 2021, Journal of clinical medicine.

[13]  G. Cho,et al.  Association of pericardial adipose tissue with left ventricular structure and function: a region‐specific effect? , 2020, Cardiovascular Diabetology.

[14]  R. D. de Boer,et al.  The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction , 2020, Cardiovascular research.

[15]  S. Heymans,et al.  Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities , 2020, Basic Research in Cardiology.

[16]  Filippo Cademartiri,et al.  Validity of epicardial fat volume as biomarker of coronary artery disease in symptomatic individuals: Results from the ALTER-BIO registry. , 2020, International journal of cardiology.

[17]  G. Kararigas,et al.  Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week. , 2020, Journal of the American College of Cardiology.

[18]  I. Shimomura,et al.  Intractable Coronary Artery Disease in a Patient With Type 2 Diabetes Presenting With Triglyceride Deposit Cardiomyovasculopathy , 2019, Diabetes Care.

[19]  Quincy A. Hathaway,et al.  Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis. , 2019, American journal of physiology. Endocrinology and metabolism.

[20]  N. Schiller,et al.  Mitral annular peak systolic and diastolic velocities are characteristic of healthy hearts: A Doppler tissue imaging study , 2018, Echocardiography.

[21]  C. Vrints,et al.  Endothelial Senescence Contributes to Heart Failure With Preserved Ejection Fraction in an Aging Mouse Model , 2017, Circulation. Heart failure.

[22]  Sanjiv J. Shah,et al.  A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure. , 2017, Journal of the American College of Cardiology.

[23]  Y. Kodama,et al.  Lack of Independent Association Between Fatty Pancreas and Incidence of Type 2 Diabetes: 5-Year Japanese Cohort Study , 2016, Diabetes Care.

[24]  S. Ng,et al.  Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure , 2015, Journal of Cardiovascular Magnetic Resonance.

[25]  S. Hamada,et al.  Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase. , 2015, International journal of cardiology.

[26]  Gianluca Iacobellis,et al.  Local and systemic effects of the multifaceted epicardial adipose tissue depot , 2015, Nature Reviews Endocrinology.

[27]  D. Rhee,et al.  Effects of the difference in tube voltage of the CT scanner on dose calculation , 2015, 1503.03563.

[28]  J. Meigs,et al.  Links Between Ectopic Fat and Vascular Disease in Humans , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[29]  M. Setou,et al.  Coronary triglyceride deposition in contemporary advanced diabetics , 2014, Pathology international.

[30]  Yoo-Seok Yoon,et al.  Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. , 2014, Radiology.

[31]  Roy Taylor.  Type 2 Diabetes , 2013, Diabetes Care.

[32]  K. Clément,et al.  Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat , 2012, International Journal of Obesity.

[33]  Ali Guermazi,et al.  Changes in paraspinal muscles and their association with low back pain and spinal degeneration: CT study , 2010, European Spine Journal.

[34]  S. Toda,et al.  Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease , 2010, Journal of Gastroenterology.

[35]  Jeroen J. Bax,et al.  Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. , 2008, Journal of the American College of Cardiology.

[36]  Benjamin D. Levine,et al.  Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.

[37]  S. Park,et al.  Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. , 2007, Radiology.

[38]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[39]  Sang Won Lee,et al.  Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.

[40]  G. Metzger,et al.  Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging , 2003, Magnetic resonance in medicine.

[41]  Jeffrey C. Hill,et al.  Influence of age on assessment of diastolic function by Doppler tissue imaging. , 2003, The American journal of cardiology.

[42]  B. Goodpaster,et al.  Composition of Skeletal Muscle Evaluated with Computed Tomography , 2000, Annals of the New York Academy of Sciences.

[43]  S. Yamashita,et al.  Abdominal fat: standardized technique for measurement at CT. , 1999, Radiology.

[44]  T. Toda,et al.  Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy. , 2018, Biochemical and biophysical research communications.

[45]  Chisayo Kozuka,et al.  Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome. , 2013, Internal medicine.

[46]  R. Califf,et al.  Metabolic syndrome: definition, pathophysiology, and mechanisms. , 2005, American heart journal.

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[48]  M. Winker,et al.  Age and the cardiovascular system. , 1993, The New England journal of medicine.